Researchers have successfully piloted the use of augmented reality for guiding tumor ablation, completing the treatment in five patients with cancers of the liver.

The technique—known as 3D cartilage surface mapping—detects subtle changes in a person’s knee joint that cannot be picked up via conventional x-ray or MRI.

Higher research and development costs are driving a need for pharmaceutical companies to leverage AI to optimize the drug discovery process––and some companies are doing so better than others.

The COVID crisis has driven mental-health issues into the medical matrix at the population level. AI may be able to help. 

What the five have in common are software products aimed at helping providers improve patient engagement by leveraging AI. The recognized companies also meet IDC’s criteria for having revenues below $100 million.

"This whole sub-branch of fMRI could go extinct if we can't address this critical limitation," said one expert who has dedicated much of his professional research to the field in question.

Vara recently announced the new capital contribution, with the venture investment arm of the Ontario Municipal Employees Retirement System pitching in the largest share.

Healthcare AI companies of all sizes need patient data to design their products and make their fortunes. Big healthcare providers have the data and need the tech partners to help advance modern medicine.